ENDOMETRIOID ENDOMETRIAL CARCINOMA: AN INSTITUTIONAL CASE SERIES

Objective: To present a case series of endometrioid endometrial carcinoma having diverse presentations, histopathological features, and therapeutic modalities. Methods: A case series of five cases of histopathologically diagnosed endometrioid endometrial carcinoma in a tertiary care center has been presented. Cases were collected over a period of 8 months (April 2017–December 2017). Results: The ages of the patients ranged from 48 to 67 years. All patients were post-menopausal and one patient was pre-menopausal. In histopathology, there were two cases of grade 1, two cases of grade 3, and a single case of grade 2. FIGO staging of the cancers ranged from stage I to stage IIIc and appropriate therapeutic modalities were used based on grading and staging of the malignancies. Conclusion: This case series highlights the clinical heterogeneity of endometrioid endometrial carcinoma. Increased education regarding early screening measures of endometrial carcinoma will aid in optimizing prevention and treatment protocols.

Authors

Institutions

Publication Details

Journal
Asian Journal of Pharmaceutical and Clinical Research
Published
2024-12-07
DOI
https://doi.org/10.22159/ajpcr.2024v17i12.52818
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ENDOMETRIOID ENDOMETRIAL CARCINOMA: AN INSTITUTIONAL CASE SERIES

Kunal Kumar
Asian Journal of Pharmaceutical and Clinical Research
Endometrial and Cervical Cancer Treatments
article

ENDOMETRIOID ENDOMETRIAL CARCINOMA: AN INSTITUTIONAL CASE SERIES

Kunal Kumar
article en

Abstract

Objective: To present a case series of endometrioid endometrial carcinoma having diverse presentations, histopathological features, and therapeutic modalities. Methods: A case series of five cases of histopathologically diagnosed endometrioid endometrial carcinoma in a tertiary care center has been presented. Cases were collected over a period of 8 months (April 2017–December 2017). Results: The ages of the patients ranged from 48 to 67 years. All patients were post-menopausal and one patient was pre-menopausal. In histopathology, there were two cases of grade 1, two cases of grade 3, and a single case of grade 2. FIGO staging of the cancers ranged from stage I to stage IIIc and appropriate therapeutic modalities were used based on grading and staging of the malignancies. Conclusion: This case series highlights the clinical heterogeneity of endometrioid endometrial carcinoma. Increased education regarding early screening measures of endometrial carcinoma will aid in optimizing prevention and treatment protocols.

Asian Journal of Pharmaceutical and Clinical Research
Institute of Medical Sciences (IN)
Good health and well-being
Openalex Percentile: Top 64%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ENDOMETRIOID ENDOMETRIAL CARCINOMA: AN INSTITUTIONAL CASE SERIES — Kunal Kumar · Asian Journal of Pharmaceutical and Clinical Research (2024) | TGRS Research Map | TGRS